TotalMarketCap

Xencor

XNCRNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.559 B

$34.10 -2.67%

Close of 6 Nov 2026

As of 6 Nov 2026, Xencor (XNCR) has a market capitalization of $2.56B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$125.6M

#2418 by revenue

Earnings

-$91.9M

Loss-making

Shares outstanding

75,039,689

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #76IDEAYA BiosciencesIDYA$2.97B
  2. #77Vicore Pharma Holding ABVCRE$2.95B
  3. #78XencorXNCR$2.56B
  4. #79Arcus BiosciencesRCUS$2.55B
  5. #80Zai LabZLAB$2.54B

What if Xencor were worth as much as…

Open the what-if tool →

Gold $28.2T

$376,292.52

Per share 11,036× higher

Bitcoin $1.53T

$20,360.53

Per share 597× higher

Apple $5.02T

$66,841.73

Per share 1,960× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Xencor are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.